MiR-139-5p Reverses CD44+/CD133+-associated Multidrug Resistance by Downregulating NOTCH1 in Colorectal Carcinoma Cells

Oncotarget - United States
doi 10.18632/oncotarget.12611
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

miR-625 Reverses Multidrug Resistance in Gastric Cancer Cells by Directly Targeting ALDH1A1

Cancer Management and Research
Oncology
2019English

Knockdown of Long Non‑coding RNA PVT1 Reverses Multidrug Resistance in Colorectal Cancer Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Baicalin Reverses Radioresistance in Nasopharyngeal Carcinoma by Downregulating Autophagy

Cancer Cell International
Cancer ResearchOncologyGenetics
2020English

MicroRNA‑139‑5P Inhibits Human Prostate Cancer Cell Proliferation by Targeting Notch1

Oncology Letters
Cancer ResearchOncology
2018English

MicroRNA‑134 Reverses Multidrug Resistance in Human Lung Adenocarcinoma Cells by Targeting FOXM1

Oncology Letters
Cancer ResearchOncology
2017English

MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells Through Regulating the Tumor Metabolism

PLoS ONE
Multidisciplinary
2016English

Furosemide Reverses Multidrug Resistance Status in Bladder Cancer Cells in Vitro

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

miR-187 Induces Apoptosis of SiHa Cervical Carcinoma Cells by Downregulating BCL-2

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2017English

MiR–20a-5p Promotes Radio-Resistance by Targeting Rab27B in Nasopharyngeal Cancer Cells

Cancer Cell International
Cancer ResearchOncologyGenetics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy